Literature DB >> 28991551

Intravenous Immunoglobulin for Heparin-Induced Thrombocytopenia.

Ibrahim F Ibrahim1, Lawrence Rice2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28991551     DOI： 10.1016/j.chest.2017.05.043

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  4 in total

1.  Use of IV Immunoglobulin G in Heparin-Induced Thrombocytopenia Patients Is Not Associated With Increased Rates of Thrombosis: A Population-Based Study.

Authors:  Binod Dhakal; Lisa Rein; Aniko Szabo; Anand Padmanabhan
Journal:  Chest       Date:  2020-03-26       Impact factor: 9.410

2.  Use of intravenous immunoglobulin G to treat spontaneous heparin-induced thrombocytopenia.

Authors:  Mehraboon Irani; Eric Siegal; Abhay Jella; Richard Aster; Anand Padmanabhan
Journal:  Transfusion       Date:  2018-12-17       Impact factor: 3.157

Review 3.  HITs and misses in 100 years of heparin.

Authors:  Lawrence Rice
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

4.  Bivalirudin as a Systemic Anticoagulant and Flush Solution Additive for Sequential Mitral and Tricuspid Valve Percutaneous Edge-to-Edge Repair in a Patient With Heparin-Induced Thrombocytopenia.

Authors:  Zachary Colbaugh; Thomas Evans Watts; Mustafa I Ahmed; Dylan R Addis
Journal:  J Cardiothorac Vasc Anesth       Date:  2021-03-06       Impact factor: 2.894
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.